FDA product code OPT: Infrared Hematoma Detector

OPT is the FDA product code for infrared hematoma detector. It is a Class II device, regulated under 21 CFR 882.1935 and reviewed by the Neurology panel. FDA has cleared 4 510(k) submissions under OPT, 2 in the last five years. The average 510(k) review took 230 days (median 235); 211 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 1 recall for OPT devices.

Definition

To employ near-infrared spectroscopy that is intended to be used to evaluate suspected brain hematomas.

Classification

FieldValue
Device nameInfrared Hematoma Detector
Device classClass II
Regulation21 CFR 882.1935
Review panelNE — Neurology
Medical specialtyOphthalmic
Premarket route510(k)

510(k) clearances per year for OPT

YearClearancesAvg. review days
20201164
20221259
20241211

Compare with all 510(k) review times · Search every OPT clearance

Top OPT applicants

ApplicantClearancesLatest
Infrascan, Inc.42024-12-12

Most recent OPT clearances

510(k)ApplicantDeviceDecision dateReview days
K241389Infrascan, Inc.Infrascanner Model 2500 (Model 2500)2024-12-12211
K211617Infrascan, Inc.Infrascanner2022-02-09259
K200203Infrascan, Inc.Infrascanner2020-07-10164
K120949Infrascan, Inc.INFRASCANNER2013-01-11287

Recalls for OPT devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2013-10-16.

Frequently asked questions

What is FDA product code OPT?

OPT is the FDA product code for infrared hematoma detector. It is a Class II device, regulated under 21 CFR 882.1935 and reviewed by the Neurology panel.

What device class is OPT?

Class II, regulation 21 CFR 882.1935. Typical premarket route: 510(k).

How long does a 510(k) take for product code OPT?

Across 4 cleared submissions the average was 230 days from receipt to decision (median 235).

Which companies have the most OPT clearances?

Infrascan, Inc. (4).

Have OPT devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2013-10-16.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times